Review
Copyright ©2012 Baishideng. All rights reserved.
World J Psychiatr. Oct 22, 2012; 2(5): 74-82
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Medication adherence in schizophrenia
Francisco Javier Acosta, José Luis Hernández, José Pereira, Judit Herrera, Carlos J Rodríguez
Francisco Javier Acosta, José Luis Hernández, José Pereira, Service of Mental Health, General Health Care Programs Direction, Canary Health Service, Las Palmas de Gran Canaria 35004, Spain
Judit Herrera, Carlos J Rodríguez, Insular University Hospital of Gran Canaria, Canary Health Service, Las Palmas de Gran Canaria 35016, Spain
Author contributions: All authors contributed to this paper; Acosta FJ coordinated and led the project.
Correspondence to: Francisco Javier Acosta, MD, PhD, Psychiatrist, Service of Mental Health, General Health Care Programs Direction, Canary Health Service, Consejería de Sanidad 3ª planta, Dirección General de Programas Asistenciales, C/ Pérez del Toro (Plaza Dr. Juan Bosch Millares, 1), Las Palmas de Gran Canaria 35004, Spain. facoart@gobiernodecanarias.org
Telephone: +34-928-302764 Fax: +34-928-302797
Received: October 24, 2011
Revised: July 12, 2012
Accepted: September 18, 2012
Published online: October 22, 2012
Abstract

Non-adherence is a major problem in the treatment of schizophrenia. Its high prevalence, potentially severe consequences and associated costs make the study of this phenomenon a priority issue. In this article, basic non-adherence concepts of prevalence, consequences, evaluation methods, methodological restrictions of available studies, risk factors and intervention strategies, are reviewed. Studying non-adherence risk factors is a necessary step toward designing adequately oriented intervention strategies. An operative definition of adherence and good knowledge of its evaluation methods are essential to study this phenomenon. Unfortunately, most available studies contain methodological restrictions, especially concerning the evaluation methods, and an agreed operative definition of adherence has only very recently been reached. Knowing non-adherence risk factors, intervention strategies and available evidence on their effectiveness is essential in making treatment decisions in daily clinical practice.

Keywords: Adherence, Non-adherence, Compliance, Noncompliance, Schizophrenia